4-122827076-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_002006.6(FGF2):c.301G>C(p.Ala101Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002006.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGF2 | ENST00000264498.9 | c.301G>C | p.Ala101Pro | missense_variant | Exon 1 of 3 | 1 | ENSP00000264498.4 | |||
FGF2 | ENST00000644866 | c.-99G>C | 5_prime_UTR_variant | Exon 1 of 3 | NM_001361665.2 | ENSP00000494222.1 | ||||
FGF2 | ENST00000608478 | c.-99G>C | 5_prime_UTR_variant | Exon 1 of 3 | 1 | ENSP00000477134.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.301G>C (p.A101P) alteration is located in exon 1 (coding exon 1) of the FGF2 gene. This alteration results from a G to C substitution at nucleotide position 301, causing the alanine (A) at amino acid position 101 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.